Recombinant allergens for immunotherapy. Where do we stand?
Authors:
- Rudolf ValentaRVRudolf Valenta
- 1 December 2004
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Allergy and Clinical Immunology
- Vol. 4 (6) , 549-554
Abstract
This review is an update regarding the development of recombinant allergens from the laboratory bench to clinical applications. Special attention will be given to the potential improvement of allergen-specific immunotherapy through the use of recombinant allergens. Currently used therapeutic allergen extracts suffer from several important disadvantages and therefore may be replaced by recombinant allergens in the near future. Recent studies indicate that recombinant allergen-based diagnostic tests can be used for selection of patients for immunotherapy and to analyse the mechanisms underlying immunotherapy. Furthermore, recombinant and peptide technologies have been used for the generation of allergy vaccines with reduced allergenic activity. Applying the new technologies, the vaccines can be formulated to target either B cells or T cells, or both cell types. Very recently, encouraging results were obtained in an immunotherapy trial performed with genetically engineered allergens. Recombinant allergen-based diagnostic tests will improve the selection of patients for immunotherapy. The first immunotherapy trial with recombinant allergens provides information about mechanisms underlying immunotherapy and holds promise that new types of allergy vaccines based on recombinant allergens will become available soon.Keywords
This publication has 64 references indexed in Scilit:
- Recombinant allergens: from production and characterization to diagnosis, treatment, and prevention of allergyMethods, 2004
- Human monoclonal antibody–based quantification of group 2 grass pollen allergensJournal of Allergy and Clinical Immunology, 2004
- How Accurate and Safe Is the Diagnosis of Hazelnut Allergy by Means of Commercial Skin Prick Test Reagents?International Archives of Allergy and Immunology, 2003
- Endotoxin content of standardized allergen vaccinesJournal of Allergy and Clinical Immunology, 2003
- Microarrayed recombinant allergens for diagnosis of allergyClinical & Experimental Allergy, 2003
- From allergen structure to new forms of allergen-specific immunotherapyCurrent Opinion in Immunology, 2002
- Environmental Exposure to Endotoxin and Its Relation to Asthma in School-Age ChildrenNew England Journal of Medicine, 2002
- The recombinant allergen‐based concept of component‐resolved diagnostics and immunotherapy (CRD and CRIT)Clinical & Experimental Allergy, 1999
- Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paperJournal of Allergy and Clinical Immunology, 1998
- False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergensJournal of Allergy and Clinical Immunology, 1996